Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

146.75 -1.66 (-1.12%)
Streaming Delayed Price Updated: 10:39 AM EST, Feb 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRhythm Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
News headline image
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for... 
Via MarketMinute
Topics Supply Chain
News headline image
iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
From iRhythm
Via GlobeNewswire
News headline image
2 Healthcare Stocks with Promising Prospects and 1 We Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but... 
Via StockStory
Topics Stocks
News headline image
1 Small-Cap Stock with Exciting Potential and 2 Facing Headwinds
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
3 Russell 2000 Stocks Worth Investigating
The Russell 2000 (^RUT) may be overshadowed by larger indexes, but it’s full of companies with the potential to deliver high returns. A select few have the right mix of innovation, market opportunity,... 
Via StockStory
News headline image
Patient Monitoring Stocks Q3 Earnings: iRhythm (NASDAQ:IRTC) Best of the Bunch
Looking back on patient monitoring stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
News headline image
iRhythm Technologies, Inc. Shares Preliminary Fourth Quarter 2025 Highlights and Business Update at the 44th Annual J.P. Morgan Healthcare Conference
From iRhythm
Via GlobeNewswire
News headline image
2 Reasons to Like IRTC (and 1 Not So Much)
Over the past six months, iRhythm has been a great trade, beating the S&P 500 by 27.6%. Its stock price has climbed to $187.29, representing a healthy 39.1% increase. This was partly due to its solid... 
Via StockStory
Topics Stocks Supply Chain
News headline image
1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 We Avoid
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
From iRhythm
Via GlobeNewswire
News headline image
Why iRhythm (IRTC) Stock Is Up Today
Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.4% in the afternoon session after Morgan Stanley raised its price target on the stock from $195 to $205. 
Via StockStory
News headline image
From Hype to P&L: Hospitals Now Buying AI That Pays
ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. 
From USA News Group
Via GlobeNewswire
News headline image
1 Mooning Stock with Promising Prospects and 2 Facing Challenges
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions. 
Via StockStory
News headline image
1 Russell 2000 Stock with Solid Fundamentals and 2 We Question
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
News headline image
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after a report revealed that the White House plans to pitch a two-year extension of Obamacare subsidies. 
Via StockStory
Topics Economy
News headline image
CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Artificial Intelligence Economy Stocks
News headline image
New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population
From iRhythm
Via GlobeNewswire
News headline image
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
How Do Investors Really Feel About iRhythm Technologies Inc? ↗
 
Via Benzinga
News headline image
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of iRhythm Technologies, Inc. – IRTC
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025
From iRhythm
Via GlobeNewswire
News headline image
5 Must-Read Analyst Questions From iRhythm’s Q3 Earnings Call
iRhythm’s third quarter results were driven by strong commercial momentum across both core Zio Monitor and Zio AT products, with management citing a record number of new account openings and expanded... 
Via StockStory
Topics Earnings
News headline image
iRhythm Technologies to Participate in Upcoming Investor Conferences
From iRhythm
Via GlobeNewswire
News headline image
IRHYTHM TECHNOLOGIES INC (NASDAQ:IRTC) Shows Strong Growth Momentum and Technical Health ↗
IRTC stock shows strong uptrend with accelerating sales and earnings growth, fitting the High Growth Momentum + Trend Template for potential continued gains. 
Via Chartmill
News headline image
iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook ↗
iRhythm Technologies beat Q3 estimates with record revenue, raised its 2025 sales outlook, and gained analyst confidence with higher price targets. 
Via Benzinga
News headline image
Why iRhythm (IRTC) Stock Is Trading Up Today
Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.2% in the afternoon session after it reported strong third-quarter financial results that surpassed expectations and... 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
IRTC Q3 Deep Dive: New Account Growth and AI Partnerships Fuel Guidance Raise
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 30.7% year on year to $192.9 million. The company’s... 
Via StockStory
Topics Artificial Intelligence
News headline image
iRhythm Technologies Inc (NASDAQ:IRTC) Surpasses Q3 Expectations and Raises 2025 Outlook ↗
iRhythm stock surges after Q3 earnings crush estimates. Revenue jumps 30.7% and the company narrows its loss, raising its full-year outlook. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.